Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4190131 | 0.83 | — | — | |
| SCHEMBL17338057 | 0.82 | — | — | |
| SCHEMBL4907261 | 0.79 | SMN1; SMN2 (0.36) | ALDH1A1 | |
| SCHEMBL8370925 | 0.78 | MEN1 (0.31) | MEN1ALDH1A1KMT2A | |
| Hydrochloric Acid SCHEMBL30804526 | 0.77 | SMN1; SMN2 (0.35) | ALDH1A1 | |
| SCHEMBL11801179 | 0.74 | SMN1; SMN2 (0.30) | — | |
| SCHEMBL4905084 | 0.71 | CTDSP1 (0.35) | — | |
| SCHEMBL3531493 | 0.71 | SMN1; SMN2 (0.33) | — | |
| Iodide SCHEMBL8592940 | 0.69 | CTDSP1 (0.37) | — | |
| SCHEMBL739514 | 0.69 | PABPC1 (0.45) | ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3698629-A1 | STABILIZATION OF METABOLICALLY-ACTIVE CELLS IN A BLOOD SAMPLE AT AMBIENT TEMPERATURES | Biomatrica, INC. (US) | 2020-08-26 | — | — | EP | claimed |
| EP-3695721-A1 | STABILIZATION OF METABOLICALLY-ACTIVE CELLS IN A BLOOD SAMPLE AT AMBIENT TEMPERATURES | Biomatrica, INC. (US) | 2020-08-19 | — | — | EP | claimed |
| EP-3155091-B1 | STABILIZATION OF METABOLICALLY-ACTIVE CELLS IN A BLOOD SAMPLE AT AMBIENT TEMPERATURES | BIOMATRICA INC (US) | 2020-04-08 | — | — | EP | claimed |
| EP-1264212-B1 | ELEMENTS FOR FORMING PRINT-OUT IMAGES | DU PONT (US) | 2009-02-18 | — | — | EP | claimed |
| CN-115768351-A | Fluid characterization method | 新生代吉恩公司 | 2023-03-07 | — | — | CN | disclosed |
| US-20230017064-A1 | METHODS FOR THE CHARACTERIZATION OF FLUID | NEXTGEN JANE, INC. | 2023-01-19 | — | — | US | disclosed |
| US-20220396836-A1 | METHODS AND SYSTEMS FOR MENSTRUALOME ANALYSIS | NEXTGEN JANE, INC. | 2022-12-15 | — | — | US | disclosed |
| CN-115066207-A | Method and system for menses group analysis | 新生代吉恩公司 | 2022-09-16 | — | — | CN | disclosed |
| EP-4051109-A1 | METHODS FOR THE CHARACTERIZATION OF FLUID | NextGen Jane, Inc. (US) | 2022-09-07 | — | — | EP | disclosed |
| EP-4051127-A1 | METHODS AND SYSTEMS FOR MENSTRUALOME ANALYSIS | NextGen Jane, Inc. (US) | 2022-09-07 | — | — | EP | disclosed |
| EP-3155395-B1 | METHODS AND COMPOSITIONS FOR STABILIZATION OF NUCLEIC ACIDS IN A BLOOD SAMPLE AT AMBIENT TEMPERATURES | BIOMATRICA INC (US) | 2021-06-02 | — | — | EP | disclosed |
| WO-2021087374-A1 | METHODS FOR THE CHARACTERIZATION OF FLUID | NEXTGEN JANE, INC. (US) | 2021-05-06 | — | — | WO | disclosed |
| US-20210000103-A1 | STABILIZATION OF METABOLICALLY-ACTIVE CELLS IN A BLOOD SAMPLE AT AMBIENT TEMPERATURES | BIOMATRICA, INC. | 2021-01-07 | — | — | US | disclosed |
| EP-3698629-A1 | STABILIZATION OF METABOLICALLY-ACTIVE CELLS IN A BLOOD SAMPLE AT AMBIENT TEMPERATURES | Biomatrica, INC. (US) | 2020-08-26 | — | — | EP | disclosed |
| EP-3695721-A1 | STABILIZATION OF METABOLICALLY-ACTIVE CELLS IN A BLOOD SAMPLE AT AMBIENT TEMPERATURES | Biomatrica, INC. (US) | 2020-08-19 | — | — | EP | disclosed |
| EP-3155091-B1 | STABILIZATION OF METABOLICALLY-ACTIVE CELLS IN A BLOOD SAMPLE AT AMBIENT TEMPERATURES | BIOMATRICA INC (US) | 2020-04-08 | — | — | EP | disclosed |
| US-20170202211-A1 | Stabilization of Metabolically-Active Cells in a Blood Sample at Ambient Temperatures | EXACT SCIENCES CORPORATION | 2017-07-20 | — | — | US | disclosed |
| US-20170198335-A1 | Stabilization of Non-Denatured Polypeptides, Nucleic Acids, and Exosomes in a Blood Sample at Ambient Temperatures | BIOMATRICA, INC. (US) | 2017-07-13 | — | — | US | disclosed |
| EP-3155091-A1 | STABILIZATION OF METABOLICALLY-ACTIVE CELLS IN A BLOOD SAMPLE AT AMBIENT TEMPERATURES | Biomatrica, INC. (US) | 2017-04-19 | — | — | EP | disclosed |
| WO-2015191634-A1 | STABILIZATION OF METABOLICALLY-ACTIVE CELLS IN A BLOOD SAMPLE AT AMBIENT TEMPERATURES | BIOMATRICA, INC. (US) | 2015-12-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170202211-A1 | Stabilization of Metabolically-Active Cells in a Blood Sample at Ambient Temperatures | G6PD, PCK2, PCK1 | MEN1 496/4885ALDH1A1 409/4885KMT2A 2163/4885 |
| US-20170198335-A1 | Stabilization of Non-Denatured Polypeptides, Nucleic Acids, and Exosomes in a Blood Sample at Ambient Temperatures | EXOSC5, EXOSC9, EXOSC10 | MEN1 2416/4885ALDH1A1 3966/4885KMT2A 3779/4885 |
| US-20210000103-A1 | STABILIZATION OF METABOLICALLY-ACTIVE CELLS IN A BLOOD SAMPLE AT AMBIENT TEMPERATURES | G6PD, PCK2, PCK1 | MEN1 496/4885ALDH1A1 409/4885KMT2A 2163/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.